(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. SHP-2 activity is required for the maintenance of expression of cardiac
markers. (A-D) Cardiac explants isolated and cultured in DMSO or
NSC-87877 beginning at stage 22. In situ hybridization performed on explants
with probes specific for Nkx2.5 (A), Tbx5 (B),
Tbx20-(C) and MLC1v' (D) at stages 22, 26, 29 and 33,
as indicated. Black arrows denote Tbx5 expression at the leading edge
of the cardiac ridge at stage 33. (E) In situ hybridization of
Nkx2.5 in uninjected (control) or Shp-2 N308D-injected
explants treated with DMSO or NSC-87877 beginning at stage 22, and assessed at
stage 37. (F) In situ with Nkx2.5 of anterior region of whole
Xenopus embryos cultured in DMSO (control) or NSC-87877. H, heart; P,
pharyngeal arches.